Azarbine composition

Details Azarbine composition Azarbine composition

1990-01-12

1991-06-11

Kight, III., John

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

424459, 424460, 424461, 424462, 424463, 424475, 424476, 424477, 424478, 424479, 424480, 424481, 424482, A61K 936

Patent

active

050230832

ABSTRACT:
A method for treating azaribine-responsive diseases in patient's who exhibit severe pyridoxal phosphate depletion following the oral administration of azaribine comprises first encapsulating azaribine in a film-forming substance which is selectively soluble in the digestive juice of the intestines. The encapsulated azaribine is then orally administered to the patient in an amount effective for the treatment of the disease, preferably in an amount to provide from about 1.5 to about 15 grams of azaribine per square meter of patient body surface area per day.

REFERENCES:
CA88(23): 163706r.
CA89(20): 168986n.
CA106(25); 207689j.

Affiliated with

Also associated with

Rating

Azarbine composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azarbine composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azarbine composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-781772